Syneos Health, Inc. (SYNH) Announces Proposed 7M Secondary Offering

Go back to Syneos Health, Inc. (SYNH) Announces Proposed 7M Secondary Offering

Syneos Health, Inc. (SYNH) Prices 7M Share Secondary Offering at $74.95/Sh

March 1, 2021 9:35 AM EST

Syneos Health, Inc. (NASDAQ: SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced the pricing of the previously announced underwritten secondary offering by affiliates of Thomas H. Lee Partners, L.P. and Advent International Corporation (the Selling Stockholders) of an aggregate of 7,000,000... More